Don't miss our weekly PhD newsletter | Sign up now Don't miss our weekly PhD newsletter | Sign up now

We have 106 Cancer Biology PhD Projects, Programmes & Scholarships for European Students (exc UK)

Discipline

Discipline

Biological Sciences

Location

Location

All locations

Institution

Institution

All Institutions

PhD Type

PhD Type

All PhD Types

Funding

Funding

I am a European student


Cancer Biology PhD Projects, Programmes & Scholarships for European Students (exc UK)

We have 106 Cancer Biology PhD Projects, Programmes & Scholarships for European Students (exc UK)

Last chance to apply

T cells under pressure

T cells under pressure. Cytotoxic CD8 T cells (CTLs) are important players in the immune response against cancer. Once activated by antigen, they migrate into tumours, adhere to their target cells and kill them by secreting a cocktail of cytotoxic enzymes. Read more

(BBSRC NWD) Harnessing organic catalysts for precision interaction mapping in ubiquitin-like systems

This PhD project focuses on the development and application of innovative tools to achieve high-resolution mapping of protein-protein interactions (PPIs) within ubiquitin-like protein (UBL) systems, addressing a critical gap in understanding cellular signalling. Read more
Last chance to apply

EASTBIO: Mapping the molecular landscape of immune checkpoints to uncover principles of immune regulation

This fully funded, 4-year PhD project is part of a competition funded by the BBSRC EASTBIO Doctoral Training Partnership. Immune checkpoints, essential modulators of immune homeostasis, govern the delicate balance between immune activation and tolerance. Read more
Last chance to apply

EASTBIO: Location,location, location: DNA damage sensors which launch protective responses to DNA damage

DNA damage happens at very high frequency in the cells in our bodies – meaning that the instructions for the proper functioning of cells could be altered unless the mistakes are spotted and corrected. Read more
Last chance to apply

EASTBIO: Hijacking new E3 ubiquitin ligases for targeted degradation of trans-membrane receptors.

Targeted protein degradation (TPD) is emerging as an exciting modality for research and therapeutic applications. Molecular glue degraders and proteolysis-targeting chimeras (PROTACs) hijack the cellular ubiquitin-proteasome (UPS) pathways to target the destruction of mainly intracellular target proteins. Read more

Investigation of loss of Y chromosome and its functional role in driving disease progression and immune evasion in cutaneous and oral squamous cell carcinoma

This CRUK Barts Cancer Bioinformatics Core funded project will commence in September 2025 and has funding for 4 years. This project would suit candidates with a background in genomics and bioinformatics and an interest in cancer genomics, spatial biology, digital pathology and sex disparities in cancer. Read more
Last chance to apply

EASTBIO: Studying kinetochore dynamics on a nanometre scale to reveal mechanisms ensuring correct chromosome segregation in mitosis

When eukaryotic cells divide, the whole set of chromosomes must be inherited by daughter cells. To ensure this, cells must correctly segregate duplicated chromosomes to opposite spindle poles during mitosis before the cell division. Read more
Last chance to apply

EASTBIO-The role of SPZ1 in cancers with deregulated Retinoblastoma (pRb) tumor suppressor protein

  Research Group: Centre for Inflammation Research
In many cancers the Retinoblastoma tumor suppressor protein pRB is either mutated or inhibited. This includes cancers that are caused by persistent infection with high risk Human Papillomaviruses (HPV) such as cervical cancer, which is one of the most frequent cancer in women world-wide. Read more
Last chance to apply

EASTBIO-Investigating phosphoinositide acyl chain composition as a novel regulator of T cell signalling during ageing

  Research Group: Centre for Inflammation Research
Healthy life expectancy is declining in the UK, particularly in deprived areas where the number of years spent in good health can vary by up to 26 years. Read more

Filtering Results